Managing Director Mr Gagan Harsh Sharma resigns effective Nov 6, 2025
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 16.1 pts less than Nifty Microcap 250 and 15.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr Gagan Harsh Sharma has resigned as Managing Director of Bliss GVS Pharma effective November 6, 2025, citing other professional commitments. He also steps down from the Audit Committee, CSR Committee, and Risk Management Committee. Mr Sharma, who is the spouse of Whole-Time Director Dr Vibha Sharma and brother-in-law of another Whole-Time Director, has also resigned from all subsidiary and associate companies, including Kremoint Pharma, Bliss GVS International (Singapore), and Asterisk Life Sciences entities. The board noted and accepted his resignation at its meeting on the same day.
Sudden MD exit on personal grounds may create short-term leadership uncertainty. No successor named yet in this filing.